Generation Bio Co. (GBIO) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Generation Bio Co. (GBIO).

Download PennyGems on Google Play Download PennyGems on the App Store

Equity Overview

Price & Market Data

Price: $0.418

Daily Change: -$0.0022 / 0.53%

Range: $0.41 - $0.44

Market Cap: $28,621,424

Volume: 316,171

Performance Metrics

1 Week: 8.93%

1 Month: -6.32%

3 Months: -54.44%

6 Months: -81.67%

1 Year: -86.90%

YTD: -59.71%

Company Details

Employees: 115

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells. It develops cell-targeted lipid nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) T cells to selectively delivery, intracellular, and genetically precise mechanism of target engagement could unlock a series of high-value historically undruggable disease-driving genes in autoimmunity. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Selected stocks

Neuraxis, Inc. (NRXS)

STAK Inc. (STAK)

FingerMotion, Inc. (FNGR)